Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This study is a Phase I clinical trial of IPI-504 in combination with docetaxel
(Taxotere).The purposes of the study are to determine:
- the safety profile,
- the highest dose of IPI-504 that can be given with docetaxel without causing severe side
effects, and
- to recommend a Phase II dose of the combination in patients with solid tumors.